These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 11473038

  • 1. Acute and short-term administration of a sulfonylurea (gliclazide) increases pulsatile insulin secretion in type 2 diabetes.
    Juhl CB, Pørksen N, Pincus SM, Hansen AP, Veldhuis JD, Schmitz O.
    Diabetes; 2001 Aug; 50(8):1778-84. PubMed ID: 11473038
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Short-term treatment with GLP-1 increases pulsatile insulin secretion in Type II diabetes with no effect on orderliness.
    Juhl CB, Schmitz O, Pincus S, Holst JJ, Veldhuis J, Pørksen N.
    Diabetologia; 2000 May; 43(5):583-8. PubMed ID: 10855533
    [Abstract] [Full Text] [Related]

  • 6. Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes.
    Juhl CB, Hollingdal M, Sturis J, Jakobsen G, Agersø H, Veldhuis J, Pørksen N, Schmitz O.
    Diabetes; 2002 Feb; 51(2):424-9. PubMed ID: 11812750
    [Abstract] [Full Text] [Related]

  • 7. Gliclazide mainly affects insulin secretion in second phase of type 2 diabetes mellitus.
    Ligtenberg JJ, Reitsma WD, van Haeften TW.
    Horm Metab Res; 2001 Jun; 33(6):361-4. PubMed ID: 11456286
    [Abstract] [Full Text] [Related]

  • 8. The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state.
    Matthews DR, Boland O.
    Metabolism; 1997 Dec; 46(12 Suppl 1):5-9. PubMed ID: 9439551
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in type 2 diabetic patients.
    Nauck MA, Weber I, Bach I, Richter S, Orskov C, Holst JJ, Schmiegel W.
    Diabet Med; 1998 Nov; 15(11):937-45. PubMed ID: 9827848
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of pancreatic beta-cell secretion in Type 2 diabetic patients treated with gliclazide and glibenclamide.
    van der Wal PS, Heine RJ.
    Diabetes Res Clin Pract; 2001 May; 52(2):103-11. PubMed ID: 11311964
    [Abstract] [Full Text] [Related]

  • 12. Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes.
    Hollingdal M, Juhl CB, Pincus SM, Sturis J, Veldhuis JD, Polonsky KS, Pørksen N, Schmitz O.
    Diabetes; 2000 Aug; 49(8):1334-40. PubMed ID: 10923634
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of acute and chronic hypoglycemic action of gliclazide.
    da Tos V, Maran A, Vigili de Kreutzenberg S, Marchetto S, Tadiotto F, Bettio M, Marescotti MC, Tiengo A, Del Prato S.
    Acta Diabetol; 2000 Aug; 37(4):201-6. PubMed ID: 11450504
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of sulphonylurea therapy on skeletal muscle glycogen synthase activity and insulin secretion in newly presenting type 2 (non-insulin-dependent) diabetic patients.
    Johnson AB, Argyraki M, Thow JC, Jones IR, Broughton D, Miller M, Taylor R.
    Diabet Med; 1991 Apr; 8(3):243-53. PubMed ID: 1828740
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of acarbose on insulin sensitivity in elderly patients with diabetes.
    Meneilly GS, Ryan EA, Radziuk J, Lau DC, Yale JF, Morais J, Chiasson JL, Rabasa-Lhoret R, Maheux P, Tessier D, Wolever T, Josse RG, Elahi D.
    Diabetes Care; 2000 Aug; 23(8):1162-7. PubMed ID: 10937515
    [Abstract] [Full Text] [Related]

  • 20. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Roberts VL, Stewart J, Issa M, Lake B, Melis R.
    Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.